Cytochrome P450 4F2 Polymorphism in Patients with Liver Cirrhosis
Authors:
- 13 December 2013
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 156 (2) , 181-184
Abstract
1297C/T polymorphism of CYP4F2 gene was studied in 108 patients with chronic liver diseases. No significant correlation with predisposition to rapid liver cirrhosis was revealed without consideration for cirrhosis etiology (OR = 0.93, 95% CI = 0.28-2.99, p = 0.885). In patients with viral cirrhosis, a tendency to association of 1297T allele genotypes with rapid cirrhosis development was found (OR = 6.0, 95% CI = 0.28-382.64, p = 0.222). At the same time, CYP4F2 1297T allele was associated with mild (Child–Pugh class A-B) cirrhosis (OR = 2.9, p = 0.044).Keywords
This publication has 13 references indexed in Scilit:
- Cytochrome P450 2D6 Polymorphism Is a Molecular Genetic Marker of Liver Cirrhosis ProgressionBulletin of Experimental Biology and Medicine, 2012
- The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsBritish Journal of Pharmacology, 2011
- Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of AnandamideDrug Metabolism and Disposition, 2010
- Common Variants of Cytochrome P450 4F2 Exhibit Altered Vitamin E-Ω-Hydroxylase Specific ActivityThe Journal of Nutrition, 2010
- The new therapeutic frontier – Nuclear receptors and the liverJournal of Hepatology, 2010
- Low affinity glucocorticoid binding site ligands as potential anti-fibrogenicsComparative Hepatology, 2009
- PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acidω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseasePPAR Research, 2009
- Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseasesBiochemical Pharmacology, 2008
- Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis CLiver International, 2006